TORONTO, ONTARIO, July 15, 2020 – NeuPath Health Inc. (TSXV:NPTH) (“NeuPath” or the “Company”), Canada’s largest provider of chronic pain management services, today filed the unaudited interim financial statements for 2576560 Ontario Inc. (“257”) for the three months ended March 31, 2020 (the “Interim Financial Statements”). The Company is filing the Interim Financial Statements in accordance with National Instrument 51-102 – Continuous Disclosure Obligations (“NI 51-102”), as 257 was the “reverse takeover acquirer” (as defined in NI 51-102) of the Company in a court approved plan of arrangement under Section 182 of the Business Corporations Act (Ontario) completed on June 25, 2020 (the “Arrangement”).

Prior to the completion of the Arrangement, the Company was a Capital Pool Company (as defined under the policies of the TSX Venture Exchange). The Company now carries on the business of 257. For further information on the Arrangement, please refer to the Company’s filing statement dated May 29, 2020 (the “Filing Statement”), which is available under the Company’s profile on SEDAR at On July 6, 2020, NeuPath commenced trading on the TSX Venture Exchange under the ticker symbol “NPTH”.

Click here to see the full PDF Press Release.